Compare HRTX & NXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRTX | NXG |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.9M | 282.2M |
| IPO Year | 2007 | N/A |
| Metric | HRTX | NXG |
|---|---|---|
| Price | $1.20 | $53.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 41.2K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.78% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | $13.08 | N/A |
| Revenue Next Year | $20.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $1.00 | $35.22 |
| 52 Week High | $2.68 | $55.20 |
| Indicator | HRTX | NXG |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 60.10 |
| Support Level | $1.07 | $46.94 |
| Resistance Level | $1.37 | $54.88 |
| Average True Range (ATR) | 0.09 | 0.86 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 51.79 | 34.17 |
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Cushing NextGen Infrastructure Income Fund is a closed-end investment management company. Its investment objective is to seek a high total return with a focus on current income. The Fund invests at least 80% of its net assets in a portfolio of equity and debt securities of infrastructure companies, including energy infrastructure companies, industrial infrastructure companies, sustainable infrastructure companies, and technology & communication infrastructure companies.